Analysts expect Niki BioSolutions, Inc. to report revenue of 2.43 M for 2023, against a range of 2.24 M to 2.62 M. The most recent reported year, 2022, came in at 1.30 M, a 4.0% miss against the 1.35 M consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Reported (Actual) | 1.54 M | 1.30 M | - | - | ||
| High Estimate | 1.32 M | 1.43 M | 2.62 M | 31.72 M | ||
| Low Estimate | 1.13 M | 1.28 M | 2.24 M | 26.82 M | ||
| Consensus Estimate | 1.23 M | 1.35 M | 2.43 M | 29.27 M |
Analysts expect Niki BioSolutions, Inc. to report earnings per share of -56.33 for 2023, against a range of -60.78 to -51.88. The most recent reported year, 2022, came in at -27.50, a 4.8% beat against the -28.89 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Reported (Actual) | -71.00 | -27.50 | - | - | ||
| High Estimate | -68.80 | -26.58 | -51.88 | -7.02 | ||
| Low Estimate | -80.36 | -31.20 | -60.78 | -7.72 | ||
| Consensus Estimate | -74.58 | -28.89 | -56.33 | -7.37 |
Pull Wall Street consensus for Niki BioSolutions, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NIKI&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NIKI", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NIKI&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();